GOSSAMER BIO, INC. (GOSS) /

The debt of GOSSAMER BIO, INC. over the past 9 years

Chart GOSSAMER BIO, INC.: liquid cash, total debt, net cash, fiscal 2017–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, GOSSAMER BIO, INC. had liquid cash of $136.93M and total debt of $198.51M: net debt of $61.58M. It had more liquid cash than debt at 7 of the 8 year-ends shown. Total debt was highest at the end of fiscal 2022 ($219.31M) and lowest at the end of fiscal 2018 ($0).

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$136.93M*$198.51M-$61.58M
2024ended Dec 31, 2024$294.52M*$197.52M$97M
2023ended Dec 31, 2023$296.43M*$209.02M$87.41M
2022ended Dec 31, 2022$255.68M*$219.31M$36.37M
2021ended Dec 31, 2021$325.22M*$179.12M$146.1M
2020ended Dec 31, 2020$512.63M*$172.39M$340.24M
2019ended Dec 31, 2019$401.77M*$28.46M$373.31M
2018ended Dec 31, 2018$228.66M*$0$228.66M
2017ended Dec 31, 2017———

Fiscal years as GOSSAMER BIO, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on GOSSAMER BIO, INC.

Companies of a similar size

Not investment advice. This page shows what GOSSAMER BIO, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.